[1]
“Pharmaceutical Care: new perspectives on pharmaceutical performance in the face of the COVID-19 pandemic”, RSD, vol. 11, no. 12, p. e182111234500, Sep. 2022, doi: 10.33448/rsd-v11i12.34500.